Role of IFN-α in Rheumatoid Arthritis

Curr Rheumatol Rep. 2024 Feb;26(2):37-52. doi: 10.1007/s11926-023-01125-6. Epub 2023 Dec 5.

Abstract

Purpose of review: Type 1 interferons (IFN-I) are of increasing interest across a wide range of autoimmune rheumatic diseases. Historically, research into their role in rheumatoid arthritis (RA) has been relatively neglected, but recent work continues to highlight a potential contribution to RA pathophysiology.

Recent findings: We emphasise the importance of disease stage when examining IFN-I in RA and provide an overview on how IFN-I may have a direct role on a variety of relevant cellular functions. We explore how clinical trajectory may be influenced by increased IFN-I signalling, and also, the limitations of scores composed of interferon response genes. Relevant environmental triggers and inheritable RA genetic risk relating to IFN-I signalling are explored with emphasis on intriguing data potentially linking IFN-I exposure, epigenetic changes, and disease relevant processes. Whilst these data cumulatively illustrate a likely role for IFN-I in RA, they also highlight the knowledge gaps, particularly in populations at risk for RA, and suggest directions for future research to both better understand IFN-I biology and inform targeted therapeutic strategies.

Keywords: Biomarkers; Early rheumatoid arthritis; Interferon gene signature; Rheumatoid arthritis; Type 1 interferons.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid* / drug therapy
  • Arthritis, Rheumatoid* / genetics
  • Autoimmune Diseases*
  • Humans
  • Interferon Type I*
  • Interferon-alpha / therapeutic use
  • Risk Factors

Substances

  • Interferon-alpha
  • Interferon Type I